Table 2.
Main characteristics of the study cohorts at baseline.
| Controls N = 11 |
Placebo N = 12 |
Nutritional Intervention N = 12 |
p | |
|---|---|---|---|---|
| Female (n,%) | 4 (36.4) | 7 (58.3) | 8 (66.7) | 1.000 |
| Age (years), mean (SD) | 10 (4.4) | 13.8 (3.6) | 10 (3.4) | 0.064 |
| Caucasian (n,%) | 7 (64) | 6 (50) | 7 (58.3) | 1.000 |
| CD4 count (cells/mm3) | - | 556 (453–754) | 852 (617–1182) | 0.0496 |
| CD4/CD8 ratio | - | 1.1 (0.56–1.67) | 1.4 (1.09–1.94) | 0.106 |
| CD4 Nadir (cells/mm3) | - | 333 (169–382) | 519 (384–979) | 0.006 |
| PI based ART (n,%) | - | 8 (66.7) | 9 (75) | 0.136 |
All values are expressed in median (IQR) except otherwise specified. ART: antiretroviral treatment. PI: protease inhibitor.